Skip to main content

Table 1 Effects of sub-chronic oral administration of P. thyrsiflorus leaf extract (PLE) and acetaminophen (ACP) on relative organ weights (ROW) of female and male Wistar rats (n = 5/sex)

From: Toxicity assessment of Phlogacanthus thyrsiflorus, a traditionally used anthelmintic plant of India

 

G-I

Control

G-II

PLE 200 mg/kg

G-III

PLE 400 mg/kg

G-IV

PLE 800 mg/kg

G-V

ACP 50 mg/kg

Satellite groups

G-VI

G-VII

G-VIII

Control

PLE 800 mg/kg

ACP 50 mg/kg

Female

Heart

0.63 ± 0.04

0.58 ± 0.01

0.60 ± 0.01

0.67 ± 0.01

0.60 ± 0.02

0.60 ± 0.02

0.67 ± 0.02

0.61 ± 0.02

Liver

5.13 ± 0.18

4.90 ± 0.16d

3.86 ± 0.07d

5.12 ± 0.17d

7.12 ± 0.11a

4.80 ± 0.15

4.41 ± 0.15 g

5.92 ± 0.11f

Brain

0.84 ± 0.02

0.86 ± 0.02

0.81 ± 0.03

0.82 ± 0.02

0.81 ± 0.02

0.83 ± 0.02

0.83 ± 0.06

0.86 ± 0.02

Spleen

0.41 ± 0.05

0.39 ± 0.01d

0.38 ± 0.01d

0.39 ± 0.03d

0.45 ± 0.02b

0.40 ± 0.02

0.38 ± 0.01

0.41 ± 0.01

Adrenal

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

Kidney (left)

0.81 ± 0.01

0.82 ± 0.02e

0.81 ± 0.02d

0.82 ± 0.01e

0.84 ± 0.01a

0.82 ± 0.01

0.81 ± 0.01

0.81 ± 0.02

Kidney (right)

0.84 ± 0.02

0.83 ± 0.01d

0.83 ± 0.02d

0.84 ± 0.01e

0.86 ± 0.01c

0.83 ± 0.01

0.82 ± 0.01

0.83 ± 0.01

Ovary

0.05 ± 0.00

0.05 ± 0.00

0.06 ± 0.00

0.05 ± 0.00

0.05 ± 0.00

0.05 ± 0.00

0.05 ± 0.00

0.05 ± 0.00

Male

Heart

0.63 ± 0.01

0.58 ± 0.01

0.63 ± 0.00

0.59 ± 0.01

0.61 ± 0.03

0.61 ± 0.02

0.61 ± 0.01

0.60 ± 0.03

Liver

7.00 ± 0.12

7.10 ± 0.29d

7.12 ± 0.13d

6.99 ± 0.14d

8.01 ± 0.11a

6.16 ± 0.19

6.22 ± 0.13 g

6.58 ± 0.11f

Brain

1.01 ± 0.06

1.00 ± 0.01

0.99 ± 0.02

0.99 ± 0.01

1.00 ± 0.03

0.97 ± 0.02

0.98 ± 0.03

0.97 ± 0.02

Spleen

0.40 ± 0.03

0.39 ± 0.02

0.37 ± 0.01

0.38 ± 0.02

0.39 ± 0.01

0.41 ± 0.01

0.39 ± 0.01

0.40 ± 0.02

Adrenal

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

Kidney (left)

0.83 ± 0.01

0.82 ± 0.00

0.82 ± 0.03

0.83 ± 0.01

0.83 ± 0.01

0.82 ± 0.02

0.83 ± 0.02

0.83 ± 0.02

Kidney (right)

0.85 ± 0.02

0.84 ± 0.00

0.84 ± 0.02

0.85 ± 0.03

0.83 ± 0.03

0.84 ± 0.02

0.85 ± 0.02

0.85 ± 0.01

Testis (left)

0.72 ± 0.02

0.73 ± 0.02

0.72 ± 0.02

0.72 ± 0.02

0.73 ± 0.02

0.73 ± 0.03

0.72 ± 0.02

0.72 ± 0.02

Testis (right)

0.76 ± 0.03

0.76 ± 0.02

0.77 ± 0.03

0.76 ± 0.03

0.77 ± 0.03

0.77 ± 0.03

0.76 ± 0.02

0.76 ± 0.03

  1. Data are expressed as mean ± S.E.M.; Treatment: G-II to G-V = 4 weeks and G-VII to G-VIII = 6 weeks; W0: week before treatment; W1 − W6: Weeks post-treatment
  2. ap < 0.001, bp < 0.01, cp < 0.05 as compared to control value; dp < 0.001, ep < 0.05 as compared to ACP values; fp < 0.001 as compared to satellite control values; gp < 0.001 as compared to satellite ACP values, one way ANOVA